Press Releases
Keyword Search
04.16.20
OpGen Subsidiary Ares Genetics Demonstrates Feasibility and Potential of Next Generation Sequencing Based Antibiotic Susceptibility Testing in Multi-Center Study
04.14.20
OpGen Announces Preliminary Unaudited Revenue and Cash Position for First Quarter 2020 and Provides Business Update
04.01.20
OpGen and Curetis Successfully Close their Business Combination Transaction
03.30.20
OpGen Announces Shareholder Approval for Business Combination with Curetis
03.24.20
OpGen Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update for OpGen and Curetis Group
03.24.20
OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis
03.23.20
OpGen Data Predicting Phenotypic Antimicrobial Susceptibility Published in Diagnostic Microbiology & Infectious Disease Journal
03.19.20
OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis
03.16.20
OpGen Provides Update on Curetis Now Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe
03.12.20
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2019